Table 1 Demographic, clinical and laboratory data of the studied population
Variables | N = 187 |
|---|---|
Female gender, n (%) | 96 (51.3) |
Age (years) | 32.2 ± 13.9 |
Age at diagnosis (years) | 15 [13] |
Diabetes duration (years) | 14 [15] |
Daily insulin dose (U/Kg/day) | 0.7 ± 0.3 |
Self-reported color-race, White, n (%) | 95 (50.3) |
Economic Status, n (%) | |
Medium | 25(13.4) |
Low | 132 (70.6) |
Very Low | 24(12.8) |
Age at menarche (years) | 12 .3 ± 1.6 |
Smoking, yes, n (%) | 15 (8) |
Exercisea, y n (%) | 82 (43.9) |
Abdominal circumference (women/men) (cm) | 81 ± 11/ 82 ± 11 |
BMI (kg/m2) | 24.2 ± 4.1 |
Systolic blood pressure (mmHg) | 124 .7 ± 16.2 |
Diastolic blood pressure (mmHg) | 74.8 ± 9.8 |
Pulse pressure (mmHg) | 50.1 ± 12.4 |
Cardiac frequency (bpm) | 78.1 ± 12.5 |
HbA1c (%/mmol/mol) | 9.1 ± 2.1/ 76 ± 2.2 |
Uric acid (mg/dL) | 3.8 ± 1.5 |
Total Cholesterol (mg/dL) | 173.7 ± 38.8 |
Triglycerides (mg/dL) | 70 [56] |
HDL-cholesterol (mg/dL) | 61.8 ± 18.5 |
LDL-cholesterol (mg/dL) | 92.8 ± 28.8 |
CRP (mg/dL) | 0.20 [0.43] |
Use of endothelial interferent drug, n (%) | 81 (43.3) |
sVCAM-1 (ng/mL) | 370.6 [277.7] |
sICAM-1 (ng/mL) | 8.3 [13.7] |
RHI | 1.7 [0.9] |
Cardiovascular risk, according to RHI, n (%) | |
High CVR; RHI ≤ 1.67 | 88 (47.1%) |
Intermediate CVR, RHI 1.68–2.00 | 43 (23.0%) |
Low CVR, RHI ≥ 2.1 | 56 (29.9%) |
Chronic complications | |
Retinopathy, y n (%) | 81 (44.4) |
Non-proliferative | 57 (30.5) |
Proliferative | 8 (4.3) |
Macular edema | 16 (8.6) |
eGFR ((mL/min/1.73 m2) | 106.2 (28.2) |